A carregar...
Position of Scientific Oncological Societies Towards Biosimilar Antibodies
First biosimilars of monoclonal antibodies have recently been approved in oncology. Biosimilars enable economic competition, alleviate the financial burden for insurances, and may facilitate access to these drugs in low-income countries. Biosimilars are not completely identical to the original drug....
Na minha lista:
| Publicado no: | Breast Care (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465735/ https://ncbi.nlm.nih.gov/pubmed/31019436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495145 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|